Cargando…

Efficacy and acceptability of the S1P receptor in the treatment of multiple sclerosis: a meta-analysis

BACKGROUND AND OBJECTIVE: Sphingosine-1-phosphate (S1P) receptors are extensively used in the treatment of multiple sclerosis (MS). However, the optimal therapeutic role of S1P in MS patients has still remained elusive. This network meta-analysis (NMA) systematically evaluated the efficacy and accep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Jingyi, Zou, Qin, Chen, Yongmin, Liao, Xiaoping, Chen, Rong, Ma, Lin, Zhang, Daqi, Li, Qifu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043952/ https://www.ncbi.nlm.nih.gov/pubmed/33523319 http://dx.doi.org/10.1007/s10072-021-05049-w

Ejemplares similares

miR-181a-5p inhibits the proliferation and invasion of drug-resistant glioblastoma cells by targeting F-box protein 11 expression
por: Wen, Xueyan, et al.
Publicado: (2020)

Iron Metabolism and Ferroptosis in Epilepsy
por: Chen, Shuang, et al.
Publicado: (2020)

SPARC Knockdown Reduces Glutamate-Induced HT22 Hippocampal Nerve Cell Damage by Regulating Autophagy
por: Chen, Shuang, et al.
Publicado: (2021)

Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment
por: Tur, Carmen, et al.
Publicado: (2013)

Variant Rs556621 on Chromosome 6p21.1 and the Risk of Ischemic Stroke in Chinese Populations: A Meta-Analysis
por: Chen, Langxin, et al.
Publicado: (2022)

Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative review
por: Capone, Fioravante, et al.
Publicado: (2022)

Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
por: Weideman, Ann Marie, et al.
Publicado: (2017)

Chemokines and Chemokine Receptors in Multiple Sclerosis
por: Cheng, Wenjing, et al.
Publicado: (2014)

Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018
por: Zhou, Ran, et al.
Publicado: (2021)

Multiple sclerosis and stroke: a systematic review and meta-analysis
por: Hong, Ye, et al.
Publicado: (2019)

Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence
por: Sabsabi, Sajida, et al.
Publicado: (2022)

Efficacy of non-invasive brain stimulation on cognitive and motor functions in multiple sclerosis: A systematic review and meta-analysis
por: Li, Shuiyan, et al.
Publicado: (2023)

A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis
por: Nikfar, Shekoufeh, et al.
Publicado: (2010)

An epidemiological survey of epilepsy in tropical rural areas of China
por: Zheng, Guoxian, et al.
Publicado: (2021)

Fatigue, Physical Disability and Self-Efficacy as Predictors of the Acceptance of Illness and Health-Related Quality of Life in Patients with Multiple Sclerosis
por: Dymecka, Joanna, et al.
Publicado: (2021)

Status of epilepsy in the tropics: An overlooked perspective
por: Liu, Jiaqi, et al.
Publicado: (2023)

The role of chemokines and chemokine receptors in multiple sclerosis
por: Cui, Li-Yuan, et al.
Publicado: (2020)

Efficacy, acceptability, and tolerability of antidepressant treatments for patients with post-stroke depression: a network meta-analysis
por: Qin, B., et al.
Publicado: (2018)

Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis
por: Sun, Yefei, et al.
Publicado: (2017)

Safety and efficacy of cladribine in multiple sclerosis: a systematic review and meta-analysis
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

The clinical characteristics of acute cerebral infarction patients with thalassemia in a tropic area in China
por: Liu, Liyuan, et al.
Publicado: (2023)

The role of microglia in multiple sclerosis
por: Luo, Chun, et al.
Publicado: (2017)

Feasibility and acceptability of time-restricted eating in a group of adults with multiple sclerosis
por: Wingo, Brooks C., et al.
Publicado: (2023)

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis
por: Amadio, Susanna, et al.
Publicado: (2017)

Efficacy and safety of siponimod for multiple sclerosis: Protocol for a systematic review and meta-analysis
por: Song, Yumeng, et al.
Publicado: (2019)

Empathy and Theory of Mind in Multiple Sclerosis: A Meta-Analysis
por: Lin, XiaoGuang, et al.
Publicado: (2021)

Functional Network Connectivity Patterns between Idiopathic Generalized Epilepsy with Myoclonic and Absence Seizures
por: Li, Qifu, et al.
Publicado: (2017)

Chemokine Receptors as Biomarkers in Multiple Sclerosis
por: Fox, Robert J., et al.
Publicado: (2006)

Melanocortins, Melanocortin Receptors and Multiple Sclerosis
por: Lisak, Robert P., et al.
Publicado: (2017)

Use and Acceptance of Electronic Communication by Patients With Multiple Sclerosis: A Multicenter Questionnaire Study
por: Haase, Rocco, et al.
Publicado: (2012)

Kinesiophobia in People with Multiple Sclerosis and Its Relationship with Physical Activity, Pain and Acceptance of Disease
por: Wasiuk-Zowada, Dagmara, et al.
Publicado: (2022)

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
por: Haddad, Fatma, et al.
Publicado: (2022)

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
por: Zhang, Yinan, et al.
Publicado: (2020)

Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis
por: Samjoo, Imtiaz A, et al.
Publicado: (2023)

Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review
por: Chen, Michelle H., et al.
Publicado: (2020)

Acceptance of the Extracare Program by Beta Interferon-Treated Patients With Multiple Sclerosis: Results of the Explore Study
por: Freidel, Matthias, et al.
Publicado: (2015)

Smoking and Multiple Sclerosis: An Updated Meta-Analysis
por: Handel, Adam E., et al.
Publicado: (2011)

Natural Killer receptors distribution in Multiple Sclerosis
por: Martinez-Rodriguez, J E, et al.
Publicado: (2010)

Multiple targets for multiple sclerosis
por: Hu, Li-Tian, et al.
Publicado: (2015)

Comparative efficacy of switching to natalizumab in active multiple sclerosis
por: Spelman, Timothy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vahbj4b7ueogj8ouke0807ll2t